Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension
10.2147/OPTH.S72380
Saved in:
Main Authors: | Sharma S., Trikha S., Perera S.A., Aung T. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Review |
Published: |
Dove Medical Press Ltd
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/145958 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension
by: Manni, G., et al.
Published: (2016) -
Noninvasive Detection of Mitochondrial Dysfunction in Ocular Hypertension and Primary Open-angle Glaucoma
by: Lawrence S. Geyman, et al.
Published: (2019) -
The role of lens extraction in the current management of primary angle-closure glaucoma
by: Trikha S, et al.
Published: (2016) -
Distinct iris gene expression profiles of primary angle closure glaucoma and primary open angle glaucoma and their interaction with ocular biometric parameters
by: Seet, Li-Fong, et al.
Published: (2023) -
Comparison of ocular response analyzer parameters in Chinese subjects with primary angle-closure and primary open-angle glaucoma
by: Narayanaswamy, A., et al.
Published: (2014)